Use of magnetite particles as a contrast agent for MR imaging of the liver.
- 1 February 1990
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 174 (2) , 357-360
- https://doi.org/10.1148/radiology.174.2.2296645
Abstract
To evaluate the potential of dextran-coated magnetite (DM) particles in enhancing the detection of hepatocellular carcinoma with magnetic resonance (MR) imaging, the authors induced liver tumors in rats by oral administration of diethylnitrosamine and examined the rats before and after intravenous injections of DM with various iron concentrations. Because of the intense and preferential T2 relaxativity of DM, use of DM with an iron concentration of 10 mumol/kg yielded effective MR signal reduction in each normal liver at 1 hour after the injection. Because no significant signal change in the tumors was observed on DM-enhanced MR images, the contrast between hepatocellular carcinoma and adjacent uninvolved liver increased remarkably on even relatively T1-weighted images. The detection rate for the 89 tumors, including small tumors less than 2 mm in diameter, increased from 10% (nine of 89) before DM administration to 65% (58 of 89) with DM-enhanced T1-weighted imaging. Iron staining of rat liver performed about 1 hour after DM administration showed sparse deposits of DM selectively in reticuloendothelial cells but not in liver tumors.This publication has 26 references indexed in Scilit:
- Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patientsAmerican Journal of Roentgenology, 1984
- Hepatic tumors: magnetic resonance and CT appearance.Radiology, 1984
- Nuclear magnetic resonance imaging: contrast-to-noise ratio as a function of strength of magnetic fieldAmerican Journal of Roentgenology, 1983
- Simultaneous determination of 20 elements in some human kidney and liver autopsy samples by inductively-coupled plasma atomic emission spectrometryScience of The Total Environment, 1982
- Clinicopathologic features of encapsulated hepatocellular carcinoma.A study of 26 casesCancer, 1977
- INTRAVENOUS IRON-DEXTRAN THERAPY IN TREATMENT OF ANEMIA OCCURRING IN SURGICAL, GYNECOLOGIC AND OBSTETRIC PATIENTS1976
- Hepatic pathology in relatives of patients with hæmochromatosisThe Journal of Pathology and Bacteriology, 1962
- Comparative Study of the Carcinogenic Activity of Nitrosamines2JNCI Journal of the National Cancer Institute, 1961
- THE EFFECT OF PARTICLE SIZE ON BLOOD CLEARANCE AND TISSUE DISTRIBUTION OF RADIOACTIVE GOLD COLLOIDS1952
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949